|
1
|
Young RC, Decker DG, Wharton JT, Piver MS,
Sindelar WF, Edwards BK and Smith JP: Staging laparotomy in early
ovarian cancer. JAMA. 250:3072–3076. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grabowski JP, Harter P, Buhrmann C, Lorenz
D, Hils R, Kommoss S, Traut A and du Bois A: Re-operation outcome
in patients referred to a gynecologic oncology center with presumed
ovarian cancer FIGO I–IIIA after sub-standard initial surgery. Surg
Oncol. 21:31–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trimbos JB, Vergote I, Bolis G, Vermorken
JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone
G, et al: Impact of adjuvant chemotherapy and surgical staging in
early-stage ovarian carcinoma: European organisation for research
and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm
trial. J Natl Cancer Inst. 95:113–125. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Timmers PJ, Zwinderman AH, Coens C,
Vergote I and Trimbos JB: Understanding the problem of inadequately
staging early ovarian cancer. Eur J Cancer. 46:880–884. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferlay J, Autier P, Boniol M, Heanue M,
Colombet M and Boyle P: Estimates of the cancer incidence and
mortality in Europe in 2006. Ann Oncol. 18:581–592. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Benedet JL, Bender H, Jones H III, Ngan HY
and Pecorelli S: FIGO staging classifications and clinical practice
guidelines in the management of gynecologic cancers. FIGO committee
on gynecologic oncology. Int J Gynaecol Obstet. 70:209–262. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
du Bois A, Reuss A, Pujade-Lauraine E,
Harter P, Ray-Coquard I and Pfisterer J: Role of surgical outcome
as prognostic factor in advanced epithelial ovarian cancer: A
combined exploratory analysis of 3 prospectively randomized phase 3
multicenter trials: By the Arbeitsgemeinschaft Gynaekologische
Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe
d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire
(GINECO). Cancer. 115:1234–1244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keetle WC and Elkin HB: Experience with
radioactive colloidal gold in the treatment of ovarian carcinoma.
Am J Obstet Gynecol. 71:553–568. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Creasman WT and Rutlidge F: The prognostic
value peritoneal cytology in gynecologic malignant disease. Am J
Obstet Gynecol. 110:773–781. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garg G, Gao F, Wright JD, Hagemann AR,
Mutch DG and Powell MA: Positive peritoneal cytology is an
independent risk-factor in early stage endometrial cancer. Gynecol
Oncol. 128:77–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fadare O, Mariappan MR, Hileeto D, Wang S,
McAlpine JN and Rimm DL: Upstaging based solely on positive
peritoneal washing does not affect outcome in endometrial cancer.
Mod Pathol. 18:673–680. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luesley DM, Williams DR, Ward K, Redman CR
and Lawton FG: Prospective comparative cytologic study of direct
peritoneal smears and lavage fluids in patients with epithelial
ovarian cancer and benign gynecologic disease. Acta Cytol.
34:539–544. 1990.PubMed/NCBI
|
|
13
|
Jadhon ME, Morgan MA, Kelsten ML, Carlson
JA Jr and Mikuta JJ: Cytologic smears of peritoneal surfaces as a
sampling technique in epithelial ovarian carcinoma. Obstet Gynecol.
75:102–105. 1990.PubMed/NCBI
|
|
14
|
Jacques SM and Selvaggi SM: Multiple
peritoneal cytologies collected during laparotomy for gynecologic
malignancy. Diagn Cytopthol. 7:482–486. 1991. View Article : Google Scholar
|
|
15
|
Sehouli J, Senyuva F, Fotopoulou C,
Neumann U, Denkert C, Werner L and Gülten OO: Intra-Abdominal tumor
dissemination pattern and surgical outcome in 214 Patients with
primary ovarian cancer. J Surg Oncol. 99:424–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Soper JT: Management of early-stage
epithelial ovarian cancer. Clin Obstet Gynecol. 37:423–438. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ozols RF, Rubin SC and Thomas G:
Epithelial ovarian cancerHoskins WJ, Perez CA and Young RC:
Principles and practice of gynecologic oncology. 4th ed.
Philadelphia: Lippincott & Wilkins; pp. 895–988. 2005
|
|
18
|
Wheeless CR Jr and Roenneburg ML: Staging
of Gynecologic Oncology Patients With Exploratory Laparotomy. Atlas
of pelvic surgery (On-Line Edition). http://www.atlasofpelvicsurgery.com/10MalignantDisease/1StagingofGynecologicOncologyPatientsWithExploratoryLaparotomy/cha10sec1.html
|
|
19
|
NCCN: Epithelial Ovarian Cancer (including
Fallopian Tube Cancer and Primary Peritoneal Cancer). Version 2.
2013.https://www.nccn.org/
|
|
20
|
Lee JY, Kim HS, Chung HH, Kim JW, Park NH
and Song YS: The role of omentectomy and random peritoneal biopsies
as part of comprehensive surgical staging in apparent early-stage
epithelial ovarian cancer. Ann Surg Oncol. 21:2762–2766. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paik ES, Lee YY, Lee EJ, Choi CH, Kim TJ,
Lee JW, Bae DS and Kim BG: Survival analysis of revised 2013 FIGO
staging classification of epithelial ovarian cancer and comparison
with previous FIGO staging classification. Obstet Gynecol Sci.
58:124–134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Piver MS, Barlow JJ and Lele SB: Incidence
of subclinical metastases in stage I and II ovarian carcinoma.
Obstet Gynecol. 52:100–104. 1978.PubMed/NCBI
|
|
23
|
Einenkel J, Ott R, Handzel R, Braumann DU
and Horn LC: Characteristics and management of diaphragm
involvement in patients with primary advanced stage ovarian,
fallopian tube, or peritoneal cancer. Int J Gynecol Cancer.
19:1288–1297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eltabbakh GH and Mount SL: Comparison of
diaphragmatic wash and scrape specimens in staging of women with
ovarian cancer. Gynecol Oncol. 81:461–465. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JY, Kim TH, Suh DH, Kim JW, Kim HS,
Chung HH, Park NH, Song YS and Kang SB: Impact of guideline
adherence on patient outcomes in early-stage epithelial ovarian
cancer. Eur J Surg Oncol. 41:585–591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buchsbaum HJ and Lifshitz S: Staging and
surgical evaluation of ovarian cancer. Semin Oncol. 11:227–237.
1984.PubMed/NCBI
|
|
27
|
Powless CA, Bakkum-Gamez JN, Aletti GD and
Cliby WA: Random peritoneal biopsies have limited value in staging
of apparent early stage epithelial ovarian cancer after thorough
exploration. Gynecol Oncol. 115:86–89. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sneige N, Thomison JB, Malpica A, Gong Y,
Ensor J and Silva EG: Peritoneal washing cytologic analysis of
ovarian serous tumors of low malignant potential to detect
peritoneal implants and predict clinical outcome. Cancer
Cytopathol. 120:238–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Giordano G, Varotti E, Brigati F and
Berretta R: The value of peritoneal washing cytology during
intra-abdominal surgery for female genital tract neoplasms. Clin
Genitourin Cancer. 12:e95–e101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Davidson W, Madan R, O'Neil M, Tawfik OW
and Fan F: Utility of peritoneal washing cytology in staging and
prognosis of ovarian and fallopian tube neoplasms: A 10-year
retrospective analysis. Ann Diagn Pathol. 22:54–57. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Anastasiadis PG, Romanidis KN,
Polichronidis A, Koutlaki NG, Tamiolakis D and Simopoulos K: The
contribution of rapid intraoperative cytology to the improvement of
ovarian cancer staging. Gynecol Oncol. 86:244–249. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Binesh F, Akhavan A, Behniafard N, Zabihi
S and Hosseinizadeh E: Prognostic value of peritoneal washing
cytology in gynecologic malignancies: A controversial issue. Asian
Pac J Cancer Prev. 15:9405–9410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Garg G, Gao F, Wright JD, Hagemann AR,
Zighelboim I, Mutch DG and Powell MA: The risk of lymph-node
metastasis with positive peritoneal cytology in endometrial cancer.
Int J Gynecol Cancer. 23:90–97. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kashimura M, Sugihara K, Toki N, Matsuura
Y, Kawagoe T, Kamura T, Kaku T, Tsuruchi N, Nakashima H and Sakai
H: The significance of peritoneal cytology in uterine cervix and
endometrial cancer. Gynecol Oncol. 67:285–290. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Havrilesky LJ, Cragun JM, Calingaert B,
Secord Alvarez A, Valea FA, Clarke-Pearson DL, Berchuck A and Soper
JT: The prognostic significance of positive peritoneal cytology and
adnexal/serosal metastasis in stage IIIA endometrial cancer.
Gynecol Oncol. 104:401–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wong FC, Pang CP, Tang SK, Tung SY, Leung
TW, Sze WK and Cheung KB: Treatment results of endometrial
carcinoma with positive peritoneal washing, adnexal involvement and
serosal involvement. Clin Oncol (R Coll Radiol). 16:350–355. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zuna RE and Behrens A: Peritoneal washing
cytology in gynecologic cancers: Long term follow up of 355
patients. J Natl Cancer Inst. 88:980–987. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mathew S and Erozan YS: Significance of
peritoneal washings in gynecologic oncology. The experience with
901 intraoperative washings at an academic medical center. Arch
Pathol Lab Med. 121:604–606. 1997.PubMed/NCBI
|
|
39
|
Lewin SN, Herzog TJ, Medel Barrena NI,
Deutsch I, Burke WM, Sun X and Wright J: Comparative performance of
the 2009 international Federation of gynecology and obstetrics'
staging system for uterine corpus cancer. Obstet Gynecol.
116:1141–1149. 2010. View Article : Google Scholar : PubMed/NCBI
|
